{"transactions":[{"id":1258483,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":83028,"kind":"organization","name":"Vickers Venture Fund VI Pte Ltd","position":1,"cik":"0001839162","reported_name":"Vickers Venture Fund VI Pte Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2025-02-19T21:48:42.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":false,"shares":3503919,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vickers Venture Fund VI Pte. Ltd."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series B Convertible Preferred Stock of the Issuer automatically converted on an 8.474-for-1 basis into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series B Convertible Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series B Convertible Preferred Stock of the Issuer automatically converted on an 8.474-for-1 basis into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series B Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series B Convertible Preferred Stock of the Issuer automatically converted on an 8.474-for-1 basis into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series B Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Vickers Venture Fund VI Pte. Ltd. (\"Vickers Fund VI\"). The sole shareholders of Vickers Fund VI are Vickers Venture Global Deep-tech Fund II (EU) SCSP-RAIF and Vickers Venture Global Deep-tech Fund II (CI) L.P. Vickers Venture Global Deep-tech Fund II (EU) SCSP-RAIF is managed by its general partner Vickers Venture Partners VI (EU) S.A.R.L. which is in turn managed by its managers, Dr. Jeffrey Chi (a member of the Issuer's Board of Directors), Dr. Finian Tan, Popescu Alexandru Ionut and Zorzetto Riccardo, who collectively exercise shared voting and dispositive power over the securities held by Vickers Fund VI. Vickers Venture Global Deep-tech Fund II (CI) L.P. is managed by its general partner Vickers Venture Partners VI (CI) Ltd. which is in turn managed by its directors, being Dr. Finian Tan and Christopher Ho, who collectively exercise shared voting and dispositive power over the securities held by Vickers Fund VI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(Continued from footnote 2) Each of Vickers Venture Global Deep-tech Fund II (EU) SCSP-RAIF, Vickers Venture Global Deep-tech Fund II (CI) L.P., Vickers Venture Partners VI (EU) S.A.R.L., Dr. Jeffrey Chi, Dr. Finian Tan, Popescu Alexandru Ionut, Zorzetto Riccardo, Vickers Venture Partners VI (CI) Ltd. and Christopher Ho disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":413491},"source":{"system":"sec-edgar","filing":"0000950170-25-023287","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1774857/000095017025023287/ownership.xml","form_type":"4"}},{"id":1258482,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":83028,"kind":"organization","name":"Vickers Venture Fund VI Pte Ltd","position":1,"cik":"0001839162","reported_name":"Vickers Venture Fund VI Pte Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2025-02-19T21:48:42.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":false,"shares":13875429,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vickers Venture Fund VI Pte. Ltd."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Convertible Preferred Stock of Aardvark Therapeutics, Inc. (the \"Issuer\") automatically converted on an 8.474-for-1 basis into shares of the Issuer's common stock (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series A Convertible Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Convertible Preferred Stock of Aardvark Therapeutics, Inc. (the \"Issuer\") automatically converted on an 8.474-for-1 basis into shares of the Issuer's common stock (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series A Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A Convertible Preferred Stock of Aardvark Therapeutics, Inc. (the \"Issuer\") automatically converted on an 8.474-for-1 basis into shares of the Issuer's common stock (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series A Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Vickers Venture Fund VI Pte. Ltd. (\"Vickers Fund VI\"). The sole shareholders of Vickers Fund VI are Vickers Venture Global Deep-tech Fund II (EU) SCSP-RAIF and Vickers Venture Global Deep-tech Fund II (CI) L.P. Vickers Venture Global Deep-tech Fund II (EU) SCSP-RAIF is managed by its general partner Vickers Venture Partners VI (EU) S.A.R.L. which is in turn managed by its managers, Dr. Jeffrey Chi (a member of the Issuer's Board of Directors), Dr. Finian Tan, Popescu Alexandru Ionut and Zorzetto Riccardo, who collectively exercise shared voting and dispositive power over the securities held by Vickers Fund VI. Vickers Venture Global Deep-tech Fund II (CI) L.P. is managed by its general partner Vickers Venture Partners VI (CI) Ltd. which is in turn managed by its directors, being Dr. Finian Tan and Christopher Ho, who collectively exercise shared voting and dispositive power over the securities held by Vickers Fund VI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(Continued from footnote 2) Each of Vickers Venture Global Deep-tech Fund II (EU) SCSP-RAIF, Vickers Venture Global Deep-tech Fund II (CI) L.P., Vickers Venture Partners VI (EU) S.A.R.L., Dr. Jeffrey Chi, Dr. Finian Tan, Popescu Alexandru Ionut, Zorzetto Riccardo, Vickers Venture Partners VI (CI) Ltd. and Christopher Ho disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1637411},"source":{"system":"sec-edgar","filing":"0000950170-25-023287","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1774857/000095017025023287/ownership.xml","form_type":"4"}},{"id":1258481,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":83028,"kind":"organization","name":"Vickers Venture Fund VI Pte Ltd","position":1,"cik":"0001839162","reported_name":"Vickers Venture Fund VI Pte Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-02-19T21:48:42.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":true,"shares":413491,"ownership":{"direct":false,"nature":"By Vickers Venture Fund VI Pte. Ltd."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series B Convertible Preferred Stock of the Issuer automatically converted on an 8.474-for-1 basis into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series B Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Vickers Venture Fund VI Pte. Ltd. (\"Vickers Fund VI\"). The sole shareholders of Vickers Fund VI are Vickers Venture Global Deep-tech Fund II (EU) SCSP-RAIF and Vickers Venture Global Deep-tech Fund II (CI) L.P. Vickers Venture Global Deep-tech Fund II (EU) SCSP-RAIF is managed by its general partner Vickers Venture Partners VI (EU) S.A.R.L. which is in turn managed by its managers, Dr. Jeffrey Chi (a member of the Issuer's Board of Directors), Dr. Finian Tan, Popescu Alexandru Ionut and Zorzetto Riccardo, who collectively exercise shared voting and dispositive power over the securities held by Vickers Fund VI. Vickers Venture Global Deep-tech Fund II (CI) L.P. is managed by its general partner Vickers Venture Partners VI (CI) Ltd. which is in turn managed by its directors, being Dr. Finian Tan and Christopher Ho, who collectively exercise shared voting and dispositive power over the securities held by Vickers Fund VI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(Continued from footnote 2) Each of Vickers Venture Global Deep-tech Fund II (EU) SCSP-RAIF, Vickers Venture Global Deep-tech Fund II (CI) L.P., Vickers Venture Partners VI (EU) S.A.R.L., Dr. Jeffrey Chi, Dr. Finian Tan, Popescu Alexandru Ionut, Zorzetto Riccardo, Vickers Venture Partners VI (CI) Ltd. and Christopher Ho disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":2050902,"source":{"system":"sec-edgar","filing":"0000950170-25-023287","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1774857/000095017025023287/ownership.xml","form_type":"4"}},{"id":1258480,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":83028,"kind":"organization","name":"Vickers Venture Fund VI Pte Ltd","position":1,"cik":"0001839162","reported_name":"Vickers Venture Fund VI Pte Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-02-19T21:48:42.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":true,"shares":1637411,"ownership":{"direct":false,"nature":"By Vickers Venture Fund VI Pte. Ltd."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Convertible Preferred Stock of Aardvark Therapeutics, Inc. (the \"Issuer\") automatically converted on an 8.474-for-1 basis into shares of the Issuer's common stock (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series A Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Vickers Venture Fund VI Pte. Ltd. (\"Vickers Fund VI\"). The sole shareholders of Vickers Fund VI are Vickers Venture Global Deep-tech Fund II (EU) SCSP-RAIF and Vickers Venture Global Deep-tech Fund II (CI) L.P. Vickers Venture Global Deep-tech Fund II (EU) SCSP-RAIF is managed by its general partner Vickers Venture Partners VI (EU) S.A.R.L. which is in turn managed by its managers, Dr. Jeffrey Chi (a member of the Issuer's Board of Directors), Dr. Finian Tan, Popescu Alexandru Ionut and Zorzetto Riccardo, who collectively exercise shared voting and dispositive power over the securities held by Vickers Fund VI. Vickers Venture Global Deep-tech Fund II (CI) L.P. is managed by its general partner Vickers Venture Partners VI (CI) Ltd. which is in turn managed by its directors, being Dr. Finian Tan and Christopher Ho, who collectively exercise shared voting and dispositive power over the securities held by Vickers Fund VI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(Continued from footnote 2) Each of Vickers Venture Global Deep-tech Fund II (EU) SCSP-RAIF, Vickers Venture Global Deep-tech Fund II (CI) L.P., Vickers Venture Partners VI (EU) S.A.R.L., Dr. Jeffrey Chi, Dr. Finian Tan, Popescu Alexandru Ionut, Zorzetto Riccardo, Vickers Venture Partners VI (CI) Ltd. and Christopher Ho disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1637411,"source":{"system":"sec-edgar","filing":"0000950170-25-023287","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1774857/000095017025023287/ownership.xml","form_type":"4"}},{"id":2115724,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":83028,"kind":"organization","name":"Vickers Venture Fund VI Pte Ltd","position":1,"cik":"0001839162","reported_name":"Vickers Venture Fund VI Pte Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See footnote (1)"}},{"id":122360,"kind":"organization","name":"Vickers Venture Fund VI (Plan) Pte Ltd","position":2,"cik":"0001839160","reported_name":"Vickers Venture Fund VI (Plan) Pte Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnote (1)"}},{"id":20713,"kind":"person","name":"Chi Jeffrey","position":3,"cik":"0001839163","reported_name":"Chi Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnote (1)"}},{"id":122361,"kind":"person","name":"Ho Chris","position":4,"cik":"0001838628","reported_name":"Ho Chris","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnote (1)"}}],"security":"Warrants","published_at":"2022-11-16T02:47:41.000Z","date":"2022-11-10","kind":"other","acquired":false,"shares":578160,"ownership":{"direct":false,"nature":"By Vickeres Venture Fund VI (Plan) Pte Ltd"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective November 10, 2022, Vickers Venture Fund VI Pte Ltd and Vickers Venture Fund VI (Plan) Pte Ltd (and indirectly by its managing members, Jeffrey Chi, the Issuer's Chief Executive Officer, and Christopher Ho, the Issuer's Chief Financial Officer) are no longer 10% Holders of Vickers Vantage Corp. I"},{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with the business combination between Scilex Holding Company (f/k/a Vickers Vantage Corp. I) with Scilex, Inc. (f/k/a Scilex Holding Company, (i) Vickers Venture Fund VI Pte Ltd forfeited 2,465,136 warrants to purchase common shares of Scilex Holding Company (\"New Scilex Warrants\") and transferred 2,796,704 New Scilex Warrants to to Sorrento Therapeutics, Inc. (\"Sorrento\") and (ii) Vickers Venture Fund VI (Plan) Pte Ltd forfeited 270,864 New Scilex Warrants and transferred 307,296 to Sorrento. Following such transfers and the forfeitures (i)\nVickers Venture Fund VI Pte Ltd holds 901,000 New Scilex Warrants and (ii) Vickers Venture\nFund VI (Plan) Pte Ltd holds 99,000 New Scilex Warrants."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the business combination between Scilex Holding Company (f/k/a Vickers Vantage Corp. I) with Scilex, Inc. (f/k/a Scilex Holding Company, (i) Vickers Venture Fund VI Pte Ltd forfeited 2,465,136 warrants to purchase common shares of Scilex Holding Company (\"New Scilex Warrants\") and transferred 2,796,704 New Scilex Warrants to to Sorrento Therapeutics, Inc. (\"Sorrento\") and (ii) Vickers Venture Fund VI (Plan) Pte Ltd forfeited 270,864 New Scilex Warrants and transferred 307,296 to Sorrento. Following such transfers and the forfeitures (i)\nVickers Venture Fund VI Pte Ltd holds 901,000 New Scilex Warrants and (ii) Vickers Venture\nFund VI (Plan) Pte Ltd holds 99,000 New Scilex Warrants."}],"balance_after":99000,"derivative":{"exercise_price":11.5,"exercise_date":"2022-11-10","expiration_date":"2027-11-10","underlying":"Common Stock","underlying_shares":578160},"source":{"system":"sec-edgar","filing":"0001104659-22-119278","document":"tm2229408-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1820190/000110465922119278/tm2229408-1_4seq1.xml","form_type":"4"}},{"id":2115723,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":83028,"kind":"organization","name":"Vickers Venture Fund VI Pte Ltd","position":1,"cik":"0001839162","reported_name":"Vickers Venture Fund VI Pte Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See footnote (1)"}},{"id":122360,"kind":"organization","name":"Vickers Venture Fund VI (Plan) Pte Ltd","position":2,"cik":"0001839160","reported_name":"Vickers Venture Fund VI (Plan) Pte Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnote (1)"}},{"id":20713,"kind":"person","name":"Chi Jeffrey","position":3,"cik":"0001839163","reported_name":"Chi Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnote (1)"}},{"id":122361,"kind":"person","name":"Ho Chris","position":4,"cik":"0001838628","reported_name":"Ho Chris","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnote (1)"}}],"security":"Warrants","published_at":"2022-11-16T02:47:41.000Z","date":"2022-11-10","kind":"other","acquired":false,"shares":5261840,"ownership":{"direct":false,"nature":"By Vickers Venture Fund VI Pte Ltd"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective November 10, 2022, Vickers Venture Fund VI Pte Ltd and Vickers Venture Fund VI (Plan) Pte Ltd (and indirectly by its managing members, Jeffrey Chi, the Issuer's Chief Executive Officer, and Christopher Ho, the Issuer's Chief Financial Officer) are no longer 10% Holders of Vickers Vantage Corp. I"},{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with the business combination between Scilex Holding Company (f/k/a Vickers Vantage Corp. I) with Scilex, Inc. (f/k/a Scilex Holding Company, (i) Vickers Venture Fund VI Pte Ltd forfeited 2,465,136 warrants to purchase common shares of Scilex Holding Company (\"New Scilex Warrants\") and transferred 2,796,704 New Scilex Warrants to to Sorrento Therapeutics, Inc. (\"Sorrento\") and (ii) Vickers Venture Fund VI (Plan) Pte Ltd forfeited 270,864 New Scilex Warrants and transferred 307,296 to Sorrento. Following such transfers and the forfeitures (i)\nVickers Venture Fund VI Pte Ltd holds 901,000 New Scilex Warrants and (ii) Vickers Venture\nFund VI (Plan) Pte Ltd holds 99,000 New Scilex Warrants."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the business combination between Scilex Holding Company (f/k/a Vickers Vantage Corp. I) with Scilex, Inc. (f/k/a Scilex Holding Company, (i) Vickers Venture Fund VI Pte Ltd forfeited 2,465,136 warrants to purchase common shares of Scilex Holding Company (\"New Scilex Warrants\") and transferred 2,796,704 New Scilex Warrants to to Sorrento Therapeutics, Inc. (\"Sorrento\") and (ii) Vickers Venture Fund VI (Plan) Pte Ltd forfeited 270,864 New Scilex Warrants and transferred 307,296 to Sorrento. Following such transfers and the forfeitures (i)\nVickers Venture Fund VI Pte Ltd holds 901,000 New Scilex Warrants and (ii) Vickers Venture\nFund VI (Plan) Pte Ltd holds 99,000 New Scilex Warrants."}],"balance_after":901000,"derivative":{"exercise_price":11.5,"exercise_date":"2022-11-10","expiration_date":"2027-11-10","underlying":"Common Stock","underlying_shares":5261840},"source":{"system":"sec-edgar","filing":"0001104659-22-119278","document":"tm2229408-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1820190/000110465922119278/tm2229408-1_4seq1.xml","form_type":"4"}}]}